文献速递头颈甲状腺与浅表US

BUS TI-RADS 2.0:基于血流形态特征优化的甲状腺结节恶性风险分层系统

BUS TI-RADS 2.0: an optimized study on a malignant risk stratification system for thyroid nodules based on morphological characteristics of blood flow.
PubMed 文献 · Eur J Radiol · 2026-09-21

本研究回顾性分析4家医院3639例患者4852个甲状腺结节,对「无放射状血流」细分为5型并重校特征权重,构建BUS TI-RADS 2.0。训练集中其AUC为0.98,内部及外部验证AUC为0.96与0.94,显著优于原BUS、ACR及C-TIRADS,且假阴性率和穿刺建议率更低。

要点

  • 环周血流改为-2分,杂乱血流+1分,无血流/点状/轮辐状血流计0分
  • 边缘模糊调整为+1分,总分决定恶性风险分层
  • 新系统假阴性率12.98%,总穿刺建议率2.97%,均低于对照系统

核心结论

  • BUS TI-RADS 2.0 在训练及验证集中诊断效能与原BUS相当,但显著优于ACR TI-RADS和C-TIRADS
  • 新系统假阴性率降至12.98%,穿刺建议率降至2.97%,提示可减少不必要活检且漏诊风险较低
  • 在训练有素的放射科医师中诊断性能已获验证,其推广尚需在非选择病例和不同经验医师中验证一致性

研究设计与样本

  • 回顾性分析4家医院2018至2025年3639例患者4852个甲状腺结节超声图像
  • 将「无放射状血流」细分为五种类型,多因素logistic回归筛选预测因子构建BUS TI-RADS 2.0
  • 与原BUS TI-RADS、ACR TI-RADS及C-TIRADS比较诊断效能并评估减少穿刺潜力

关键影像表现/征象

  • 血管分布征象细分为环周血流、杂乱血流、无血流、点状血流及轮辐状血流,各自赋予不同分值
  • 边缘模糊作为独立征象在BUS TI-RADS 2.0中调整为+1分
  • 结论总评分决定的恶性风险分层为该系统最终诊断输出,具体分层截断值见criteria栏目

诊断标准与关键数值

  • 血管征重新评分:环周血流-2分,杂乱血流+1分,无血流/点状/轮辐状血流均计0分
  • 边缘模糊在BUS TI-RADS 2.0中计+1分
  • 训练集中BUS TI-RADS 2.0的AUC为0.98,高于原BUS TI-RADS的0.97、ACR TI-RADS的0.94和C-TIRADS的0.93,所有比较P<0.001
  • 内部验证中BUS TI-RADS 2.0与原系统AUC相等,均为0.96;外部验证中两者AUC相等,均为0.94,均显著优于其他系统P<0.001

临床应用与阅片要点

  • 阅片时应对结节血流形态按环周、杂乱、无血流、点状、轮辐状进行分类并分别计-2、+1、0、0、0分
  • 报告边缘模糊结节时在新版系统中应计+1分,与原系统存在差异,需注意版本适用性
  • BUS TI-RADS 2.0总分决定风险分层,可依据分层结果向临床提供更少的穿刺建议

局限性

  • 研究对象为4家医院回顾性病例,可能存在选择偏移
  • 验证结果在训练有素的放射科医师中取得,不同经验水平的医师一致性尚需评估
  • 原文建议在非选择病例及不同阅片经验人群中进一步验证一致性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To upgrade the baseline ultrasound thyroid imaging reporting and data system 2.0 (BUS TI-RADS 2.0) by refining nonradiating vascularity subclassification and recalibrating feature weights to enhance diagnostic accuracy and clinical utility.

METHODS: The ultrasonic images of 4852 thyroid nodules of 3639 patients in 4 hospitals (2018-2025) were retrospectively analyzed. "Non-radiating vascularity" was subclassified into five types. Multivariable logistic regression identified predictors to construct BUS TI-RADS 2.0. Its performance was compared with the original BUS TI-RADS, American College of Radiology TI-RADS (ACR TI-RADS), and Chinese TIRADS (C-TIRADS), and biopsy-reducing potential was assessed.

RESULTS: Multivariate regression confirmed established predictors (e.g., composition, echogenicity, shape, margin, suspected extrathyroidal extension, punctate echogenic foci, vascularity). Diverging from BUS TI-RADS, BUS TI-RADS 2.0 rescored vascularity: circumferential vascularity (-2 points), disorganized vascularity (+1 point), and avascular/punctate/wheel-like vascularity (0 points); "ill-defined margin" was also adjusted to + 1 point. The final score determined risk stratification. BUS TI-RADS 2.0 achieved an AUC of 0.98 in the training set, significantly outperforming BUS TI-RADS (0.97), ACR TI-RADS (0.94), and C-TIRADS (0.93) (all P < 0.001). Internal/external validation confirmed comparable diagnostic value to BUS TI-RADS (AUCs: 0.96 vs. 0.96; 0.94 vs. 0.94) and superiority over others (P < 0.001). The new system markedly reduced false-negative rates (12.98% vs. 18.05%-68.70%), and yielded low overall biopsy recommendations (2.97% vs. 3.53%-34.08%).

CONCLUSIONS: With proven diagnostic performance in trained radiologists, BUS TI-RADS 2.0 may effectively inform clinical decision-making. Broader adoption now depends on validating its consistency across unselected cases and varying reader expertise.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Huang, Zhu, Lei, et al. BUS TI-RADS 2.0: an optimized study on a malignant risk stratification system for thyroid nodules based on morphological characteristics of blood flow. Eur J Radiol. 2026. PMID: 42800239. doi:10.1016/j.ejrad.2026.113249

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。